Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phosphoric Diester Hydrolases”

Showing 9 of 0 results

Early research (Phase 1)Study completedNCT00767598
What this trial is testing

The Effect of CYP3A Genetic Polymorphism on the Pharmacokinetics of Phosphodiesterase type5 Inhibitors in Male Subjects

Who this might be right for
Pharmacokinetics of Three PDE5IsHealthy SubjectsGenetic Polymorphic CYP3A5
Inje University 21
Post-approval studies (Phase 4)Study completedNCT00512707
What this trial is testing

Effect of Testosterone in Men With Erectile Dysfunction

Who this might be right for
Erectile DysfunctionTestosterone DeficiencyDiabetes
Boston University 140
Testing effectiveness (Phase 2)Study completedNCT00011375
What this trial is testing

Rolipram to Treat Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 52
Not applicableEnded earlyNCT03592212
What this trial is testing

Phosphodiesterase 4 Gene Variant and Salbutamol Response in Persistent Childhood Asthma

Who this might be right for
Asthma
Assistance Publique - Hôpitaux de Paris 99
Testing effectiveness (Phase 2)WithdrawnNCT04751071
What this trial is testing

The Phosphodiesterase 4 Inhibitor Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients

Who this might be right for
Major Depressive Disorder
Sadat City University
Not applicableStudy completedNCT00874185
What this trial is testing

Satisfaction With Phosphodiesterase 5 Inhibitors Treatment In Patients With Cardiovascular Risk

Who this might be right for
Erectile Dysfunction
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 720
Post-approval studies (Phase 4)Study completedNCT00617305
What this trial is testing

Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1)

Who this might be right for
Pulmonary Arterial Hypertension
Gilead Sciences 38
Testing effectiveness (Phase 2)Study completedNCT04094207
What this trial is testing

Pentoxifylline as an Adjunctive in Treatment of Negative Symptoms in Chronic Schizophrenia

Who this might be right for
Schizophrenia
Sadat City University 80
Testing effectiveness (Phase 2)Study completedNCT00708916
What this trial is testing

Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhibitor in Cutaneous Lupus Patients

Who this might be right for
Discoid Lupus Erythematosus
NYU Langone Health 8

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation